Elevated use of cannabis, nicotine among U.S. adults continues into 2025 - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Increased Consumption of Cannabis and Nicotine Among U.S. Adults Persists Through 2025

  • August 12, 2026

Share

Clinical Scorecard: Increased Consumption of Cannabis and Nicotine Among U.S. Adults Persists Through 2025

At a Glance

CategoryDetail
ConditionSubstance Use Trends
Key MechanismsIncreased cannabis and nicotine vaping usage among adults, with a notable rise in heroin use among young adults.
Target PopulationU.S. adults aged 19 to 65
Care SettingPublic health surveillance and intervention

Key Highlights

  • Cannabis use among adults reached record-high levels in 2025.
  • Nicotine vaping among young adults tripled in past 30 days since 2017.
  • Cigarette smoking rates remained low, with 8.3% in young adults.
  • Heroin use among young adults increased from 0.2% in 2024 to 0.6% in 2025.
  • Nonmedical use of sleeping medications rose from 2.0% in 2024 to 3.0% in 2025.

Guideline-Based Recommendations

Diagnosis

  • Ongoing surveillance of substance use trends is essential.

Management

  • Formulate public health interventions based on evolving drug use patterns.

Monitoring & Follow-up

  • Utilize longitudinal studies to detect shifts in substance use.

Risks

  • Increased prevalence of cannabis and nicotine use may lead to public health challenges.

Patient & Prescribing Data

Adults aged 19 to 65 in the U.S.

Low rates of cigarette smoking and alcohol consumption contrast with rising cannabis and nicotine use.

Clinical Best Practices

  • Implement targeted public health strategies to address rising substance use.
  • Monitor demographic trends in substance use for effective resource allocation.

Related Resources & Content

Original Source(s)

Related Content